Clinical trials show tirzepatide produces weight loss of 2022% in some patients, compared to 1518% for semaglutide alone
BodySpec looked at a subset of their own patients, many of which were undergoing GLP-1 treatment, who had lost 50+ lbs over the last yea
A total of 1,961 adult participants with a BMI of at least 30 or at least 27 with at least one weight-related comorbidity were randomized to receive either semaglutide (2.4 mg) or placebo, administered subcutaneously once weekly, along with lifestyle intervention
any such effect should be considered in the context of individual experience rather than as a certainty
Slowing Digestion: By slowing the emptying of the stomach, these drugs help control portion sizes and reduce overall calorie intake
While many people explore BPC-157 for recovery support, joint and tendon wellness, active lifestyle goals, and soft tissue support, questions about safety and side effects remain among the most common concerns